133 related articles for article (PubMed ID: 17212186)
21. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
Rose M; Zielen S
Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.
Ray GT; Pelton SI; Klugman KP; Strutton DR; Moore MR
Vaccine; 2009 Nov; 27(47):6483-94. PubMed ID: 19720366
[TBL] [Abstract][Full Text] [Related]
23. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
24. The public health ramifications of pneumococcal resistance.
Reinert RR
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():1-3. PubMed ID: 19366361
[No Abstract] [Full Text] [Related]
25. Cost-effectiveness of pneumococcal vaccine.
Meyerhoff AS; Jacobs RJ
JAMA; 2000 Jul; 284(4):440-1. PubMed ID: 10904500
[No Abstract] [Full Text] [Related]
26. New insights on pneumococcal disease: what we have learned over the past decade.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
[TBL] [Abstract][Full Text] [Related]
27. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
Nigrovic LE; Kuppermann N; Malley R;
Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
[TBL] [Abstract][Full Text] [Related]
28. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
Aguilar L; Giménez MJ
Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
[No Abstract] [Full Text] [Related]
29. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Prymula R
Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
[TBL] [Abstract][Full Text] [Related]
30. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
Dagan R
Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
[TBL] [Abstract][Full Text] [Related]
31. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
Farrell DJ; Klugman KP; Pichichero M
Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
[TBL] [Abstract][Full Text] [Related]
32. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
33. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
34. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Traut V
Dtsch Med Wochenschr; 2008 May; 133(22):1207-8; author reply 1208. PubMed ID: 18491279
[No Abstract] [Full Text] [Related]
35. [Invasive pneumococcal diseases in children and surveillance systems in Italy].
Bagnato B; Marino MG; Franco E
Ig Sanita Pubbl; 2008; 64(6):811-22. PubMed ID: 19219089
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
[TBL] [Abstract][Full Text] [Related]
38. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
[TBL] [Abstract][Full Text] [Related]
39. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
Beall B
Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
[No Abstract] [Full Text] [Related]
40. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
Adam D; Fehnle K
Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
